Targeting conserved TIM3 <sup>+</sup> VISTA <sup>+</sup> tumor-associated macrophages overcomes resistance to cancer immunotherapy
Isaure Vanmeerbeek(Cell Medica (Switzerland)), Abhishek D. Garg(KU Leuven)
Cited by 56
Related Papers
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
|The EMBO Journal|2012|772
Classification of current anticancer immunotherapies
|Oncotarget|2014|469
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
|Frontiers in Immunology|2015|389
Necroptosis in Immuno-Oncology and Cancer Immunotherapy
|Cells|2020|172